J
Joanna M. Biernacka
Researcher at Mayo Clinic
Publications - 265
Citations - 11003
Joanna M. Biernacka is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Bipolar disorder & Medicine. The author has an hindex of 40, co-authored 216 publications receiving 7815 citations. Previous affiliations of Joanna M. Biernacka include University of Rochester & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
A genome-wide association study of antidepressant-induced mania
Clement C. Zai,Alessio Squassina,Arun K. Tiwari,Claudia Pisanu,Marco Pinna,Federica Pinna,Anna Maria Meloni,Pasquale Paribello,Bernardo Carpiniello,Leonardo Tondo,Mark A. Frye,Joanna M. Biernacka,Brandon J. Coombes,James L. Kennedy,Mirko Manchia +14 more
TL;DR: The first genome-wide association study of AIM in 814 bipolar disorder patients of European ancestry was conducted in this article . But no significant findings from single-marker or gene-based analyses were reported.
Journal ArticleDOI
Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders
Nicolas A. Nunez,Christopher L. Sola,Simon Kung,Balwinder Singh,Ayşegül Özerdem,Marin Veldic,Paul E. Croarkin,Katherine M. Moore,Hannah K. Betcher,Jennifer L. Vande Voort,Jennifer R. Geske,Joanna M. Biernacka,Teresa A. Rummans,Rebecca S. Bahn,Mark A. Frye +14 more
TL;DR: In this article, a post-hoc analysis of a randomized, double-blind, placebo-controlled trial of concurrent liothyronine (T3-Cytomel® n = 23; mean dose 46.3±3.3 mcg) in patients with major depression where a clinical recommendation was made to pursue ECT.
Posted ContentDOI
Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder
Marisol Herrera-Rivero,Karina Gutiérrez-Fragoso,Anbupalam Thalamuthu,Azmeraw T. Amare,Mazda Adli,Kazufumi Akiyama,Nirmala Akula,Raffaella Ardau,Bárbara Arias,Jean-Michel Aubry,Lena Backlund,Frank Bellivier,Antoni Benabarre,Susanne Bengesser,Joanna M. Biernacka,Armin Birner,Micah Cearns,Pablo Cervantes,Hsi-Chung Chen,Caterina Chillotti,Sven Cichon,Scott R. Clark,Francesc Colom,Cristiana Cruceanu,Piotr M. Czerski,Nina Dalkner,Franziska Degenhardt,Maria Del Zompo,J. Raymond DePaulo,Bruno Etain,Peter Falkai,Ewa Ferensztajn-Rochowiak,Andreas J. Forstner,Josef Frank,Louise Frisén,Mark A. Frye,Janice M. Fullerton,Sébastien Gard,Julie Garnham,Fernando S. Goes,Maria Grigoroiu-Serbanescu,Paul Grof,Ryota Hashimoto,Roland Hasler,Joanna Hauser,Urs Heilbronner,Stefan Herms,Per Hoffmann,Liping Hou,Yi-Hsiang Hsu,Stéphane Jamain,Esther Jiménez,Jean-Pierre Kahn,Layla Kassem,Tadafumi Kato,John R. Kelsoe,Sarah Kittel-Schneider,Po-Hsiu Kuo,Joachim Kurtz,Ichiro Kusumi,Barbara König,Gonzalo Laje,Mikael Landén,Catharina Lavebratt,Marion Leboyer,Susan G. Leckband,Mario Maj,Mirko Manchia,Cynthia Marie-Claire,Lina Martinsson,Michael McCarthy,Susan L. McElroy,Vincent Millischer,Marina Mitjans,Francis M. Mondimore,Palmiero Monteleone,Caroline M. Nievergelt,Thomas P. Novak,Markus M. Nöthen,C. Odonovan,Norio Ozaki,Sergi Papiol,Andrea Pfennig,Claudia Pisanu,James B. Potash,Andreas Reif,Eva Z. Reininghaus,Hélène Richard-Lepouriel,Gloria Roberts,Guy A. Rouleau,Janusz K. Rybakowski,Martin Schalling,Peter R. Schofield,Klaus Oliver Schubert,Eva C. Schulte,Barbara W. Schweizer,Giovanni Severino,Tatyana Shekhtman,Paul D. Shilling,Kazutaka Shimoda,Christian Simhandl,Claire Slaney,Alessio Squassina,Thomas Stamm,Pavla Stopkova,Fabian Streit,Fasil Tekola Ayele,Alfonso Tortorella,Gustavo Turecki,Julia Veeh,Eduard Vieta,Biju Viswanath,Stephanie H. Witt,Peter P. Zandi,Martin Alda,Michael Bauer,Francis J. McMahon,Philip B. Mitchell,Marcella Rietschel,Thomas G. Schulze,Bernhard T. Baune +120 more
TL;DR: In this article , the authors investigated the contributions of immune-relevant genetic factors to the response to lithium (Li) treatment and the clinical presentation of bipolar disorder (BP) and found a relatively weak association between immunity and clinically relevant features of BP at the genetic level.
Posted ContentDOI
Multi-ancestry meta-analysis of tobacco use disorders based on electronic health record data prioritizes novel candidate risk genes and reveals associations with numerous health outcomes
Sylvanus Toikumo,Mariela V Jennings,B. Pham,Hyunjoon Lee,Travis T. Mallard,Sevim B Bianchi,John J. Meredith,Laura Vilar-Ribó,Heng Xu,Alexander S. Hatoum,Emma C. Johnson,Vanessa M. Pazdernik,Z. Jinwala,Maria Niarchou,Greg D. Jenkins,Anthony Batzler,Richard S. Pendegraft,Abraham A. Palmer,Hang Zhou,Joanna M. Biernacka,Brandon J. Coombes,Joel Gelernter,Ke Xu,Dana B. Hancock,Nancy J. Cox,Jordan W. Smoller,Lea K. Davis,Amy C. Justice,Henry R. Kranzler,Rachel L. Kember,Sandra Sanchez-Roige +30 more
TL;DR: In this article , a multi-ancestral meta-analysis of tobacco use disorder (TUD) was performed using electronic health records (EHR) in 898,680 individuals (739,895 European, 114,420 African American, 44,365 Latin American).
Journal ArticleDOI
Gene‐based polygenic score analysis identifies novel immune genes with deleterious variants that associate with Alzheimer’s disease
Joseph S. Reddy,Xue Cheng Wang,Mariet Allen,Minerva M. Carrasquillo,Joanna M. Biernacka,Jenkins D. Gregory,Brandon J. Coombes,Nilufer Ertekin-Taner,Steven G. Younkin +8 more
TL;DR: The authors used gene-based polygenic score analysis (PGSA) to evaluate an immune, temporal cortical co-expression network with 229 genes including TREM2.pR47H.